GTAB B — Glycorex Transplantation AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK65.73m
- SEK63.36m
- SEK29.96m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 6.88 | -8.05 | -12.2 | -8.52 | -30.4 |
Depreciation | |||||
Non-Cash Items | 0.245 | -0.086 | 0.166 | 8.52 | 0.149 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.74 | 1.57 | 2.88 | -0.622 | -0.585 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 9.47 | 1.26 | -0.695 | -0.622 | -9.46 |
Capital Expenditures | -3.6 | -2.01 | -2.55 | -2.13 | -3.55 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | 0.235 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -3.6 | -2.01 | -2.55 | -1.9 | -3.55 |
Financing Cash Flow Items | — | 39.9 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.25 | 34.5 | -3.79 | -6.02 | -6.63 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.41 | 33.7 | -7.17 | -8.55 | -19.7 |